Clinical Trials Directory

Trials / Completed

CompletedNCT00769821

The Impact of Lymphedema on Breast Cancer Survivors

The Impact of Lymphedema on Local and Overall Functioning

Status
Completed
Phase
Study type
Observational
Enrollment
145 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
Female
Age
21 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Gathering information from breast cancer survivors about lymphedema; its symptoms and their impact on shoulder, arm, and hand functioning; and quality of life may help doctors learn more about the disease. PURPOSE: This clinical trial is studying the impact of lymphedema on breast cancer survivors.

Detailed description

OBJECTIVES: * To determine the relationship between degree of lymphedema, lymphedema-associated symptoms, and local upper extremity functioning. * To determine the relationship between degree of lymphedema, lymphedema-associated symptoms, local upper extremity functioning, and overall health-related functioning. * To determine the relationship between degree of lymphedema, lymphedema-associated symptoms, local upper extremity functioning, overall health-related functioning, and quality of life. OUTLINE: Patients are stratified according to presence of lymphedema (yes vs no). Patients complete self-reporting questionnaires to assess the degree of lymphedema using the Norman Questionnaire and Jane M. Armer's Lymphedema and Breast Cancer Questionnaire; lymphedema-associated symptoms using Symptoms in the Affected Breast/Mastectomy site questionnaire, Symptoms in the Shoulder, Arm, or Hand on the Affected Side questionnaire, and General Symptom Experience questionnaire; local upper extremity functioning using hand dominance questionnaire and the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire; quality of life (QOL) using the Multidimensional QOL Scale; and comorbidity using the Charleston Comorbidity Scale. Patients undergo a 3.5-hour testing to assess the degree of lymphedema by arm circumference and bioimpedance spectroscopy (BIS); local upper extremity functioning by strength testing, range of movement and neurodynamic testing using a goniometer, a skin examination, skin sensation and sensation at scar using the Semmes-Weinstein Monofilament test, and fine motor control/finger coordination using the Purdue Pegboard, Finger Tapper, and Vibration Threshold; and overall health-related functioning using a graded exercise test.

Conditions

Interventions

TypeNameDescription
OTHERquestionnaire administration
PROCEDUREassessment of therapy complications
PROCEDUREbioimpedance spectroscopy
PROCEDUREquality-of-life assessment

Timeline

Start date
2007-02-01
Primary completion
2009-02-01
Completion
2009-02-01
First posted
2008-10-09
Last updated
2012-12-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00769821. Inclusion in this directory is not an endorsement.